Summary:
This podcast features a panel discussion from the 2024 Chief Medical Officer Summit 360° on how biotech CMOs evolved the ways that they pitched to different investors and how their approaches evolved over time, including lessons learned to make the most of investor interactions.
To learn more about the CMO Summit 360°, please visit CMO360.org.
Moderators
Howard Rutman, MD, MBA
CMO
Xalud Therapeutics
Panelists
Daniel Chung, DO, MA
CMO
Beacon Therapeutics
Scott Harris, MD
Senior Strategic Advisor
Altimmune
Robert Brown, MD
CMO, Oncology
Zai Laboratory
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.